Physician profile
John Kim
NPI 1194828517
$2,487.53
in general payments reported to CMS, 2019-2025
16 companies · $327 in 2025
The $327 reported for 2025 was less than what a typical Gastroenterology (Internal Medicine) provider received nationally (typical 2025 total: $636).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $732 · 2020: $63.74 · 2022: $134 · 2023: $535 · 2024: $696 · 2025: $327.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,459 · Education: $99.00.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,459.15 |
| Education | $99.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $1,050.25 | 2019-2025 | |
| Janssen Biotech, INC. | $279.53 | 2019-2025 | Stelara, Tremfya |
| Takeda Pharmaceuticals U.S.A., INC. | $269.68 | 2019-2024 | Entyvio |
| Gilead Sciences, INC. | $197.48 | 2019-2024 | |
| Cook Medical LLC | $111.55 | 2019 | |
| Lilly USA, LLC | $106.45 | 2024 | Omvoh |
| Celgene Corporation | $87.34 | 2023-2024 | Zeposia |
| Novo Nordisk INC | $73.94 | 2025 | Wegovy |
| Boston Scientific Corporation | $72.95 | 2024-2025 | Axonics |
| Pfizer INC. | $70.67 | 2019 | |
| Bausch & Lomb Americas INC. | $38.59 | 2025 | Miebo |
| Allergan, INC. | $36.81 | 2019 | |
| Braintree Laboratories, INC. | $33.19 | 2019 | |
| Intercept Pharmaceuticals, INC. | $30.00 | 2024 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $15.42 | 2023 | Xifaxan |
Show all 16 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Boehringer Ingelheim Pharmaceuticals, INC. | $13.68 | 2023 | Cyltezo |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw John Kim listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.